Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells
2008 ◽
Vol 154
(3)
◽
pp. 632-638
◽
2007 ◽
Vol 205
(3)
◽
pp. S36
2008 ◽
Vol 374
(2)
◽
pp. 258-263
◽
2009 ◽
Vol 386
(4)
◽
pp. 598-601
◽
Keyword(s):
Keyword(s):
Keyword(s):